In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Self-administered gerocognitive exam improves detection of cognitive issues in primary care
Jul 02, 2024
Detection rates appear to increase during nonacute office visits.
Patient–primary care provider language concordance tied to better outcomes
Jul 02, 2024
The findings were seen for non-English and non-French speakers living in Canada.
American Diabetes Association, June 21-24
Jul 01, 2024
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians,...
Few with type 2 diabetes receive guideline-recommended CKD screening
Jul 01, 2024
24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening
CDC advises updated COVID vaccine for everyone over 6 months of age
Jun 28, 2024
Americans 65 and older account for two-thirds of COVID hospitalizations and 82% of in-hospital deaths, yet only about 40% of Americans in that age group were immunized with the COVID vaccines that were...
Dysbiosis in phylogenetically diverse species associated with type 2 diabetes
Jun 26, 2024
Within-species phylogenetic diversity was identified for strains of 27 species that explain inter-individual differences in type 2 diabetes risk.
Substituting lower-wage staff for registered nurses tied to worse outcomes
Jun 25, 2024
Harms include avoidable patient deaths, readmissions, longer lengths of stay, excess Medicare costs and forgone cost savings.
Cannabis use tied to risk of COVID-19 hospitalizations, ICU admissions
Jun 25, 2024
The findings persisted even after considering cigarette smoking, vaccination status, comorbidities and other risk factors.
Medically advised aspirin use lower in 2021 than 2012 to 2017
Jun 24, 2024
Compared with 2012 to 2017, in 2021, medically advised aspirin use for primary prevention was lower (19.3 versus 27.6 to 31.2% among adults aged 60 to 69 years; 30.6 versus 38.35 to 41.6% among those aged...